Michael H. Zoller
Otolaryngology
5201 Frederick St
Savannah, GA 31405
Savannah, GA 31405
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Maribavir in lung transplant recipients with cytomegalovirus infection: real-life experience.
Journal: Infection
Published: June 22, 2026
Real-World Data on the Effectiveness and Use of Intravenous Fosfomycin for the Treatment of Difficult-to-Treat Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria-A Subgroup Analysis from the FORTRESS Study.
Journal: Infectious diseases and therapy
Published: April 23, 2026
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study.
Journal: Infectious diseases and therapy
Published: April 21, 2026
Efficacy of Intravenous Immunoglobulin in Eliminating De Novo Donor-Specific Antibodies After Lung Transplantation: Importance of Early Intervention.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: July 30, 2025
Towards model-informed precision dosing of intravenous linezolid: a multicentre external evaluation of pharmacokinetic models in critically ill adults.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 03, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimization.
Journal: The Journal of antimicrobial chemotherapy
Published: April 07, 2025
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study.
Journal: Infectious diseases and therapy
Published: January 28, 2025
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study.
Journal: Infection
Published: December 12, 2024
Reply to Gatti and Pea, "Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?"
Journal: Antimicrobial agents and chemotherapy
Published: November 06, 2024
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study.
Journal: Biomedicines
Published: September 17, 2024
Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantation.
Journal: Infection
Published: August 05, 2024
Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
Journal: Antimicrobial agents and chemotherapy
Published: July 31, 2024
Last Updated: 09/26/2026